13 April 2023 | Thursday | News
Image Source : Public Domain
Part of the B2B and marketing intelligence company IMAPAC’s BioPharma Awards, the ceremony, which took place on March 15, celebrates outstanding achievements in the Asian bioprocessing industry. The awards applaud exceptional leaders, organizations and technologies that facilitate innovation and best practice in manufacturing in the region.
“We are honored to have been recognized by the Asia-Pacific biopharma community for our pioneering work to address cell culture media and bioprocessing challenges, to help improve processes and performance,” said Shirley Qi, president Southeast Asia, Australia & New Zealand/head of Nutrition & Care Asia Pacific at Evonik.
Evonik’s extensive Cell Culture Solutions portfolio combines considerable development expertise and manufacturing capabilities to provide highly defined and pure cell culture ingredients for use in a wide range of applications, from biopharmaceutical R&D and manufacturing to medicinal purposes.
“This award underscores our commitment to providing first-class solutions to our customers. We will continue to push the boundaries of biopharmaceutical technology to drive the industry forward,” said Spandan Mishra, associate director business development for biopharma solutions at Evonik Health Care for Asia Pacific.
Evonik’s solutions include the cQrex® portfolio of peptides which address specific amino acid limitations to improve stability and solubility, enabling optimal productivity and enhancing performance in biopharma cell culture media.
Evonik’s Health Care business line is a global innovation hub to the world’s leading pharma and biotech companies. By leveraging six decades of industry leadership, the company provides the biopharma market with high-quality Cell Culture Solutions including amino acids, peptides, plant-based lipids and other non-animal-derived performance boosters.
The ABEA awards ceremony was held in conjunction with the 10th annual Biologics Manufacturing Asia 2023 conference.